Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Reexam Litigation Search ... Venting

Especially if the search for institutional investors was successful - meaning, they are standing on the sidelines and waiting for a re-validation of the patents to start purchasing PTSC shares?



This is only an opinion....but I highly doubt there are any institutional investors waiting for our PTO outcome. We won't see any significant investment by the 'big boys' until we are traded on a major exchange. No institution is going to invest any serious money in an OTC company.

Share
New Message
Please login to post a reply